![Foto de María Jose](/img/nophoto.png)
María Jose
Calasanz Abínzano
Publications dans lesquelles il/elle collabore avec María Jose Calasanz Abínzano (9)
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2022
-
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Science Advances, Vol. 8, Núm. 3
2021
-
Endogenous retroelement activation by epigenetic therapy reverses the warburg effect and elicits mitochondrial-mediated cancer cell death
Cancer Discovery, Vol. 11, Núm. 5, pp. 1268-1285
2018
-
Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73
2016
2010
-
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
Blood, Vol. 116, Núm. 14, pp. 2531-2542
2003
-
Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: Clinical and genetic features of two cases
Cancer Genetics and Cytogenetics, Vol. 143, Núm. 2, pp. 178-181
2002
-
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome
Genes Chromosomes and Cancer, Vol. 35, Núm. 1, pp. 11-19
1997
-
Estudio clínico y evolutivo de la leucemia de células plasmáticas. A propósito de nueve casos
Revista Clinica Espanola, Vol. 197, Núm. 5, pp. 341-345